Aurobindo Pharma informs about press release

26 Apr 2025 Evaluate
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by CuraTeQ Biologics s.r.o, a wholly owned stepdown subsidiary of the Company in connection with the receipt of Positive Opinion from CHMP for Dazublys®, a Trastuzumab Biosimilar.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1205.95 -6.70 (-0.55%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×